HomeStock ScreenerRemedium LifecareFinancial Statements

Remedium Lifecare Complete Financial Statements

1 Years of Data
2025 - 2025

In FY2025, Remedium Lifecare (REMLIFE) reported revenue ₹114 Cr, net profit ₹9 Cr and EPS ₹0.10, with a net profit margin of 7.9% and ROE of 20.5%. Full financial statements from FY2025 to FY2025 (1 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Review REMLIFE P/E comparison to evaluate earnings-based valuation against sector peers.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 7.89% 2025 data
EBITDA Margin 9.65% 2025 data
Operating Margin 7.00% 2025 data
Return on Assets 0.52% 2025 data
Return on Equity 20.45% 2025 data

Balance Sheet Ratios

Debt to Equity 39.09 2025 data
Equity Ratio 2.56% 2025 data
Asset Turnover 0.07 2025 data

REMLIFE Revenue, Net Profit & EBITDA — Year-on-Year Growth

REMLIFE YoY (Mar 2025 vs Sept 2025) — revenue -57.0%, net profit +550.0%, expenses -60.8%. Explore REMLIFE fundamental worth to estimate fundamental worth using multiple valuation models.

Revenue Growth
-57.0%
Year-over-Year
Net Profit Growth
+550.0%
Year-over-Year
Expense Growth
-60.8%
Year-over-Year

REMLIFE Income Statement — Revenue, EBITDA & Net Profit

Remedium Lifecare revenue ₹114 Cr, EBITDA ₹11 Cr, net profit ₹9 Cr, EPS ₹0.10 (2025) — net profit margin 7.9%. For live price, earnings ratios and company overview, see Remedium Lifecare share price screener.

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025
Revenue 114 265 117
Expenses 104 265 112
EBITDA 11 0 5
Operating Profit Margin % 7.00% 0.00% 2.00%
Depreciation 0 0 0
Interest 0 2 0
Profit Before Tax 10 -1 6
Tax 2 1 1
Net Profit 9 -2 5
Earnings Per Share (₹) 0.10 -0.05 0.05

REMLIFE Balance Sheet — Assets, Liabilities & Shareholders' Equity

REMLIFE total assets ₹1,720 Cr, total equity ₹44 Cr, total liabilities ₹1,720 Cr (2025) — ROE 20.5%.

Years Annual Data ₹ Crores
Particulars 2025
ASSETS
Total Assets 1,720
Current Assets 1,720
Fixed Assets 0
Capital Work in Progress 0
Investments 0
Other Assets 1,720
LIABILITIES
Total Liabilities 1,720
Current Liabilities 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 44
Share Capital 40
Reserves & Surplus 4

REMLIFE Cash Flow Statement — Operating, Investing & Financing

Remedium Lifecare operating cash flow ₹-1,135 Cr, investing ₹0 Cr, financing ₹1,136 Cr, net cash flow ₹1 Cr (2025).

Periods ₹ Crores
Particulars March 2025
Operating Activities -1,135
Investing Activities 0
Financing Activities 1,136
Net Cash Flow 1